30 results on '"Kass-Hout O"'
Search Results
2. Performance and Predictive Value of a User-Independent Platform for CT Perfusion Analysis: Threshold-Derived Automated Systems Outperform Examiner-Driven Approaches in Outcome Prediction of Acute Ischemic Stroke
- Author
-
Dehkharghani, S., primary, Bammer, R., additional, Straka, M., additional, Albin, L.S., additional, Kass-Hout, O., additional, Allen, J.W., additional, Rangaraju, S., additional, Qiu, D., additional, Winningham, M.J., additional, and Nahab, F., additional
- Published
- 2015
- Full Text
- View/download PDF
3. E-019 Clinical, Angiographic, and Radiographic Outcomes Differences Amongst Mechanical Thrombectomy Devices: Initial Experience of a Large-Volume Centre
- Author
-
Kass-Hout, T, primary, Kass-Hout, O, additional, Sun, C, additional, Gupta, R, additional, and Nogueira, R, additional
- Published
- 2013
- Full Text
- View/download PDF
4. O-024 A Cost-Effectiveness Analysis of Mechanical Thrombectomy for Acute Ischaemic Stroke in the Stent-Retriever ERA
- Author
-
Kass-Hout, T, primary, Kass-Hout, O, additional, Sun, C, additional, Gupta, R, additional, and Nogueira, R, additional
- Published
- 2013
- Full Text
- View/download PDF
5. E-074 Intravenous thrombolysis and endovascular therapy for acute ischemic stroke with internal carotid artery occlusion: a systematic review of clinical outcomes
- Author
-
Mokin, M, primary, Kass-Hout, T, additional, Kass-Hout, O, additional, Dumont, T, additional, Kan, P, additional, Snyder, K, additional, Siddiqui, A, additional, and Levy, E, additional
- Published
- 2012
- Full Text
- View/download PDF
6. E-071 CT perfusion as a tool to predict the risk of hemorrhagic transformation in ischemic stroke treated with tissue plasminogen activator: a single center experience
- Author
-
Kass-Hout, T, primary, Kass-Hout, O, additional, Al Masry, M, additional, Mokin, M, additional, Wack, D, additional, Nourollahzadeh, E, additional, Siddiqui, A, additional, Levy, E, additional, and Synder, K, additional
- Published
- 2012
- Full Text
- View/download PDF
7. E-072 Wake up symptomatic stroke in acute brain ischemia (WASSABI) clinical trial
- Author
-
Kass-Hout, T, primary, Kass-Hout, O, additional, Mokin, M, additional, Al Masry, M, additional, Nourollahzadeh, E, additional, Siddiqui, A, additional, Levy, E, additional, and Synder, K, additional
- Published
- 2012
- Full Text
- View/download PDF
8. P-045 The role of bridging with intravenous thrombolysis in endovascular therapy of acute ischemic stroke
- Author
-
Kass-Hout, O, primary, Kass-Hout, T, additional, Mokin, M, additional, Siddiqui, A, additional, Levy, E, additional, and Synder, K, additional
- Published
- 2012
- Full Text
- View/download PDF
9. P-046 Correlation between recanalization rate and good clinical outcome in acute ischemic stroke, a meta-analysis
- Author
-
Nourollahzadeh, E, primary, Kass-Hout, O, additional, Mokin, M, additional, Aliotta, R, additional, Synder, K, additional, Siddiqui, A, additional, Levy, E, additional, and Kass-Hout, T, additional
- Published
- 2012
- Full Text
- View/download PDF
10. P-005 Is bridging with intravenous thrombolysis of any benefit in endovascular therapy of acute ischemic stroke?
- Author
-
Kass-Hout, T., primary, Mokin, M., additional, Kass-Hout, O., additional, Darkhabani, M., additional, Orion, D., additional, Jahshan, S., additional, Yashar, P., additional, Levy, E., additional, Siddiqui, A., additional, and Snyder, K., additional
- Published
- 2011
- Full Text
- View/download PDF
11. FreeClimb 88 catheter with Tenzing 8 delivery for contact aspiration mechanical thrombectomy of anterior circulation large vessel occlusions.
- Author
-
Alexander MD, Caldwell J, Lee SS, Kim WT, English JD, Kim J, McGuinness BJ, Page M, Belachew NF, Grossberg JA, Tonetti D, Khalife J, Shaikh H, Kass-Hout O, Colasurdo M, Priest R, Varjavand B, Khangura RS, Chaudhry TA, and Settecase F
- Abstract
Purpose: Contact aspiration mechanical thrombectomy (CAMT) with 0.088-inch catheters may improve first-pass success rates, but delivery of such catheters can be challenging and limit effectiveness. This study examines the initial multicenter experience using the FreeClimb 88 catheter paired with the Tenzing 8 delivery catheter., Materials and Methods: Retrospective analysis was performed of consecutive patients with large vessel occlusion (LVO) of the internal carotid artery (ICA) or M1 segment of the middle cerebral artery treated with off-label CAMT using the FreeClimb 88 and Tenzing 8 at eight sites participating in the early limited release for these devices. Demographic and procedural variables were collected and analyzed with descriptive statistics and multivariable analysis., Results: Fifty-three consecutive patients were treated. Large vessel occlusion was located in the ICA in 19/53 (35.8%) patients; 34/53 (64.2%) were in the M1 segment. FreeClimb 88 was successfully delivered to the site of occlusion in 50/53 (94.3%) of patients. First-pass TICI 2c or 3 was achieved with FreeClimb 88 delivered by Tenzing 8 in 36 (67.9%) cases. Among cases with successful FreeClimb 88 delivery 9/50 (18.0%) required additional smaller devices to perform thrombectomy of distal occlusions after recanalization of the initial LVO. No complications or symptomatic hemorrhages occurred following thrombectomy., Conclusion: Contact aspiration mechanical thrombectomy performed for ICA or M1 LVOs using FreeClimb 88 delivered with Tenzing 8 was safe, effective, and efficient in this early experience, with first-pass TICI 2c or 3 was achieved in 68% of patients without procedural complications occurring in any cases., Competing Interests: Author contributionsConcept and design (FS, MDA, JDE), analysis and interpretation (MDA, FS, JDE), data collection (all authors), writing the article (MDA, FS), critical revision of the article (MDA, FS, JC, SL, WTK, JDE), final approval of the article (all authors), statistical analysis (MDA, FS), and overall responsibility (MDA, FS, JDE). Declaration of conflicting interestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: MDA: Consultant fees, Route 92 Medical. Stock or stock options, Certus Critical Care, Route 92 Medical, Piraeus Medical. JC: Consultant fees and travel/meeting Support, Route 92 Medical. SL: Consultant fees and travel/meeting Support, Route 92 Medical. WTK: Consultant fees, Stryker Neurovascular; Consultant fees, Travel reimbursements, and Stock Options, Route 92 Medical. JDE: Consultant fees, Stryker Neurovascular; Consultant fees, Travel reimbursements, and Stock Options, Route 92 Medical, Co-founder and Chief Medical Officer, Route 92 Medical. JAG: Consultant fees, Imperative Care, Route 92, Cognition; Grant Support, Emory Medical Care Foundation, Neurosurgery Catalyst, Department of Defense-Surgical Critical Care Initiative, Georgia Research Alliance. DT: Consultant fees Route 92, Scientia; Speaker fees, IRRAS. RP: Consultant fees, Stryker, Medtronic, Route 92 Medical; Grant Support, Phenox. FS: Consultant fees, Stryker Neurovascular and Route 92 Medical; Honoraria for lectures, Stryker Neurovascular; Travel, Medtronic; Research Grants: Microvention, Stryker. Stock or Stock Options: Route 92 Medical
- Published
- 2024
- Full Text
- View/download PDF
12. A rare dissecting anterior inferior cerebellar artery aneurysm treated with flow diversion using a silk vista baby device.
- Author
-
Kass-Hout O, Darkhabani Z, and Becske T
- Abstract
Background: Dissecting intracranial pseudoaneurysms represent a challenge for treatment both endovascularly and surgically., Methods: We review the treatment course of a ruptured anterior inferior cerebellar artery (AICA) dissecting pseudoaneurysm in a 50-year-old patient and review the history of dissecting aneurysms and AICA aneurysms treatment., Results: An aneurysm cure was achieved using flow diversion in the AICA. The recent introduction of flow diversion devices that can be deployed through 0.017" microcatheters represents a new avenue for treatment of aneurysms., Conclusion: To the best of our knowledge this is the first published case of flow diversion in the(?) AICA to treat a dissecting aneurysm. The introduction of Silk Vista Baby and similar future devices is likely to widen the scope of aneurysm treatment utilizing flow diversion in distal distribution with small parent arteries., Competing Interests: Declaration of conflicting interestsThe authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF
13. An alternative reduced dose regimen of ticagrelor for neuroendovascular patients.
- Author
-
Kass-Hout O, Stern J, D Tangonan R, Morsi RZ, Thind S, Kass-Hout T, and Guterman L
- Subjects
- Humans, Clopidogrel pharmacology, Hemorrhage chemically induced, Retrospective Studies, Treatment Outcome, Platelet Aggregation Inhibitors adverse effects, Ticagrelor adverse effects
- Abstract
Objective: There is a growing use of ticagrelor in patients undergoing neuroendovascular procedures, especially those who demonstrate clopidogrel resistance. While multiple dosages are studied in the cardiology literature, the optimal dose for patients with neurological pathology has yet to be established. Here, we describe a single center experience involving 39 patients who underwent neuroendovascular procedures that then received an adjusted lower dose of ticagrelor., Methods: A retrospective chart review was performed between 2013 and 2017 for patients on dual anti-platelet therapy (DAPT) for either cervical or intracranial vascular pathologies, as well as stenting of the neurovasculature, including carotid arteries. Patients were placed on ticagrelor if their measured P2Y
12 reaction units (PRU) responses to clopidogrel were outside the expected range in our center using the VerifyNow™ P2Y12 test. All patients were maintained on a dose of 45 mg twice daily except for one patient who received 22.5 mg twice daily. Responsiveness to ticagrelor were measured utilizing the VerifyNow™ P2Y12 test., Results: The mean number of days for follow-up post treatment initiation was 532 days. A total of 39 patients were included in the analysis. Of these, 8 patients (21%) received implantation of intracranial stents (5 patients received pipeline embolization devices, 1 patient received stent-assisted coiling, and 2 patients received intracranial stents for atherosclerotic disease). Fourteen patients (35%) received carotid angioplasty and stenting. Seventeen patients (44%) did not receive permanent implantation of a stent. All patients on the lower dose ticagrelor of 45 mg twice daily achieved responsiveness (i.e., PRU < 194). Hemorrhagic transformation of ischemic stroke occurred in one patient (2.5%). No other hemorrhagic complications were encountered. No thromboembolic events were recorded aside from one patient (2.5%) with intracranial atherosclerotic disease who had an ischemic event., Conclusions: A lower dose of ticagrelor (45 mg twice daily) appears to be safe and effective in this small cohort of patients who are resistant to clopidogrel per P2Y12 testing and who have increased risk of ischemic or hemorrhagic strokes due to neurovascular pathologies and implants. Further randomized studies are required to confirm these findings., Competing Interests: Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.- Published
- 2023
- Full Text
- View/download PDF
14. Retrograde thrombectomy of basilar artery thrombus through the posterior communicating artery.
- Author
-
Kass-Hout O and Becske T
- Subjects
- Circle of Willis, Humans, Stents, Thrombectomy, Treatment Outcome, Basilar Artery diagnostic imaging, Basilar Artery surgery, Thrombosis diagnostic imaging, Thrombosis surgery
- Abstract
Transcirculation thrombectomy through the communicating arteries of the circle of Willis has been previously described as a bailout in cases where direct thrombectomy is not feasible.1-3 Here we present a unique case where a retrograde thrombectomy of the proximal basilar artery was performed using the right posterior communicating artery (PCOM) in a patient with bilateral occlusions of the vertebral arteries, believed to be chronic. This was done using a quadriaxial system with multiple concentric catheters to minimize the ledge effect and achieve smooth and safe transition of the catheters from anterior to posterior circulations. A combination of stent retrieval, aspiration and balloon occlusion guide catheters helped retrieve the thrombus, while minimizing emboli in new territory (ENT). The patient had complete resolution of symptoms. The thrombus is believed to be due to stasis at the vertebrobasilar junction and competing flow, hence, the patient was started on anticoagulation. (video 1) neurintsurg;14/6/634/V1F1V1Video 1Disclaimer: this video summarises a scientific article published by BMJ Publishing Group Limited (BMJ). The content of this video has not been peer-reviewed and does not constitute medical advice. Any opinions expressed are solely those of the contributors. Viewers should be aware that professionals in the field may have different opinions. BMJ does not endorse any opinions expressed or recommendations discussed. Viewers should not use the content of the video as the basis for any medical treatment. BMJ disclaims all liability and responsibility arising from any reliance placed on the content., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2022
- Full Text
- View/download PDF
15. Performance of the vision, aphasia, neglect (VAN) assessment within a single large EMS system.
- Author
-
Patel MD, Thompson J, Cabañas JG, Williams JG, Lewis E, Bachman M, Al Masry M, LaVigne C, Morantes L, Becske T, and Kass-Hout O
- Subjects
- Humans, Predictive Value of Tests, Retrospective Studies, Aphasia diagnosis, Aphasia etiology, Brain Ischemia diagnosis, Emergency Medical Services, Stroke diagnosis
- Abstract
Background: There is limited evidence on the performance of emergent large-vessel occlusion (LVO) stroke screening tools when used by emergency medical services (EMS) and emergency department (ED) providers. We assessed the validity and predictive value of the vision, aphasia, neglect (VAN) assessment when completed by EMS and in the ED among suspected stroke patients., Methods: We conducted a retrospective study of VAN performed by EMS providers and VAN inferred from the National Institutes of Health Stroke Scale performed by ED nurses at a single hospital. We calculated sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of VAN by EMS and in the ED for LVO and a combined LVO and intracerebral hemorrhage (ICH) outcome., Results: From January 2018 to June 2020, 1,547 eligible patients were identified. Sensitivity and specificity of ED VAN were similar for LVO (72% and 74%, respectively), whereas EMS VAN was more sensitive (84%) than specific (68%). PPVs were low for both EMS VAN (26%) and ED VAN (21%) to detect LVO. Due to several VAN-positive ICHs, PPVs were substantially higher for both EMS VAN (44%) and ED VAN (39%) to detect LVO or ICH. EMS and ED VAN had high NPVs (97% and 96%, respectively)., Conclusions: Among suspected stroke patients, we found modest sensitivity and specificity of VAN to detect LVO for both EMS and ED providers. Moreover, the low PPV in our study suggests a significant number of patients with non-LVO ischemic stroke or ICH could be over-triaged with VAN., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2022
- Full Text
- View/download PDF
16. How to Improve the Management of Acute Ischemic Stroke by Modern Technologies, Artificial Intelligence, and New Treatment Methods.
- Author
-
Zeleňák K, Krajina A, Meyer L, Fiehler J, Esmint Artificial Intelligence And Robotics Ad Hoc Committee, Behme D, Bulja D, Caroff J, Chotai AA, Da Ros V, Gentric JC, Hofmeister J, Kass-Hout O, Kocatürk Ö, Lynch J, Pearson E, and Vukasinovic I
- Abstract
Stroke remains one of the leading causes of death and disability in Europe. The European Stroke Action Plan (ESAP) defines four main targets for the years 2018 to 2030. The COVID-19 pandemic forced the use of innovative technologies and created pressure to improve internet networks. Moreover, 5G internet network will be helpful for the transfer and collecting of extremely big databases. Nowadays, the speed of internet connection is a limiting factor for robotic systems, which can be controlled and commanded potentially from various places in the world. Innovative technologies can be implemented for acute stroke patient management soon. Artificial intelligence (AI) and robotics are used increasingly often without the exception of medicine. Their implementation can be achieved in every level of stroke care. In this article, all steps of stroke health care processes are discussed in terms of how to improve them (including prehospital diagnosis, consultation, transfer of the patient, diagnosis, techniques of the treatment as well as rehabilitation and usage of AI). New ethical problems have also been discovered. Everything must be aligned to the concept of "time is brain".
- Published
- 2021
- Full Text
- View/download PDF
17. Intravenous Clevidipine for Inducing Hypotensive Challenge During Carotid Balloon Test Occlusion.
- Author
-
Tarlov N, Kass-Hout O, Guterman LR, and Qureshi AI
- Subjects
- Aged, Blood Pressure drug effects, Carotid Artery, Internal, Humans, Infusions, Intravenous, Male, Antihypertensive Agents administration & dosage, Balloon Occlusion methods, Hypotension chemically induced, Pyridines administration & dosage
- Published
- 2018
- Full Text
- View/download PDF
18. Atrial Fibrillation Predictors on Mobile Cardiac Telemetry in Cryptogenic Ischemic Stroke.
- Author
-
Kass-Hout O, Kass-Hout T, Parikh A, Hoskins M, Clements SD Jr, Rangaraju S, Noorian AR, Ayala L, Blanke D, Bamford L, Anderson A, Belagaje S, Yepes M, Frankel M, and Nahab F
- Abstract
Background and Purpose: The objective of our study was to evaluate magnetic resonance imaging (MRI) and echocardiographic characteristics that would identify patients with cryptogenic ischemic stroke (IS) and transient ischemic attack (TIA) who subsequently developed paroxysmal atrial fibrillation (PAF) on mobile cardiac outpatient telemetry (MCOT)., Methods: All patients with cryptogenic IS or TIA seen at the Emory University Hospital and Emory University Hospital Midtown from January 1, 2009, to June 30, 2013, who underwent MCOT were included in this analysis. Location (cortical, high subcortical, or neither) of current and prior strokes on MRI and left atrial (LA) functional and anatomical echocardiographic parameters were evaluated to determine their association with subsequent detection of PAF., Results: Of 132 patients, 17 (13%) had evidence of newly diagnosed PAF on MCOT (mean duration of monitoring = 25 days). The presence (vs absence) of ≥1 cortical infarct on baseline MRI was a significant predictor of identifying PAF (odds ratio: 5.2, 95% confidence interval: 1.3-19; P = .01). On baseline echocardiography, patients who had PAF (vs non-PAF) had significantly higher mean LA diameters (4.2 vs 3.7 cm, P = .03) and lower tissue Doppler velocity (a'; 5.5 vs 13.5 cm/s, P = .03). In receiver operating characteristic analysis, the ratio of LA volume index to the septal Doppler velocity (LAVI/a') of >4.6 was associated with a higher likelihood of PAF. Combining MRI with echocardiographic variables did not improve the predictive ability beyond echocardiography alone., Conclusion: Although the presence of cortical-based infarcts on MRI in patients with cryptogenic IS or TIA increases the likelihood of detecting PAF on MCOT, LA functional and anatomic parameters alone best predicted which patients subsequently had PAF., Competing Interests: Declaration of Conflicting Interests: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2018
- Full Text
- View/download PDF
19. Longer procedural times are independently associated with symptomatic intracranial hemorrhage in patients with large vessel occlusion stroke undergoing thrombectomy.
- Author
-
Kass-Hout T, Kass-Hout O, Sun CJ, Kass-Hout TA, Nogueira R, and Gupta R
- Abstract
Background: Time to reperfusion is an essential factor in determination of outcomes in acute ischemic stroke (AIS)., Objective: To establish the effect of the procedural time on the clinical outcomes of patients with AIS., Methods: Data from all consecutive patients who underwent mechanical thrombectomy between September 2010 and July 2012 were analysed retrospectively. The variable of interest was procedural time (defined as time from groin puncture to final recanalization time). Outcome measures included the rates of symptomatic intracranial hemorrhage (sICH, defined as any parenchymal hematoma-eg, PH-1/PH-2), final infarct volume, 90-day mortality, and independent functional outcomes (modified Rankin Scale 0-2) at 90 days., Results: The cohort included 242 patients with a mean age of 65.5±14.2 and median baseline National Institutes of Health Stroke Scale score 20. 51% of the patients were female. The mean procedure time was significantly shorter in patients with a good outcome (86.7 vs 73.1 min, respectively, p=0.0228). Patients with SICH had significantly higher mean procedure time than patients without SICH (79.67 vs 104.5 min, respectively; p=0.0319), which remained significant when controlling for the previous factors (OR=0.974, 95% CI 0.957 to 0.991). No correlation was found between the volume of infarction and the procedure time (r=0.10996, p=0.0984). No association was seen between procedure time and 90-day mortality (77.8 vs 88.2 min in survivals vs deaths, respectively; p=0.0958)., Conclusions: Our data support an association between the risk of SICH and a longer procedure time, but no association between procedural times and the final infarction volume or long-term functional outcomes was found., Competing Interests: Competing interests: RN: Stryker Neurovascular (Trevo-2 and DAWN Trials principal instigator); Covidien (SWIFT and SWIFT Prime Trials Steering Committee; STAR Trial Angiographic Core Laboratory), Penumbra (3D Separator Trial Executive Committee), Rapid Medical (Stroke Trial Data Safety Monitoring Board). RG: consultant: Stryker Neurovascular, Covidien, Rapid Medical; Steering Committee for Penumbra THERAPY trial; associate editor Journal of Neuroimaging; associate editor Interventional Neurology; royalties from UpToDate., (Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.)
- Published
- 2016
- Full Text
- View/download PDF
20. Clopidogrel plus Aspirin for Symptomatic Intracranial Atherosclerotic Stenosis: A Pilot Study.
- Author
-
Kass-Hout T, Winningham M, Kass-Hout O, Henriquez L, Tong F, Dion J, Cawley M, Belagaje S, Frankel M, Anderson A, and Nahab F
- Abstract
Background and Purpose: There are limited data on the optimal duration of dual antiplatelet therapy for secondary stroke prevention in patients with symptomatic intracranial atherosclerotic disease., Methods: Consecutive patients presenting with high-grade (70-99%) symptomatic intracranial stenosis from January 1, 2011, to December 31, 2013, and evaluated within 30 days of the index event were eligible for this analysis. All patients underwent treatment with aspirin plus clopidogrel for a target duration of 12 months along with aggressive medical management based on the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) protocol; all patients were given gastrointestinal prophylaxis for the duration of their aspirin and clopidogrel treatment. Clinical and safety outcomes of our cohort were compared with the medical arm of the SAMMPRIS trial cohort (n = 227)., Results: Our cohort included 25 patients that met the inclusion criteria. Achievement of blood pressure and LDL cholesterol targets were similar between our cohort and the SAMMPRIS cohort. At 1 year, the rates of stroke, myocardial infarction or vascular death were 0% in our cohort and 16% in the SAMMPRIS cohort (p = 0.03). At 1 year, major bleeding rates were similar between our cohort and the SAMMPRIS cohort (4 vs. 2.2%, p = 1.0)., Conclusion: A prolonged course of dual antiplatelet therapy for symptomatic intracranial atherosclerotic disease may be associated with less vascular events with no increase in hemorrhagic complications.
- Published
- 2016
- Full Text
- View/download PDF
21. Arteriovenous Malformations in the Pediatric Population: Review of the Existing Literature.
- Author
-
El-Ghanem M, Kass-Hout T, Kass-Hout O, Alderazi YJ, Amuluru K, Al-Mufti F, Prestigiacomo CJ, and Gandhi CD
- Abstract
Arteriovenous malformations (AVMs) in the pediatric population are relatively rare but reportedly carry a higher rate of rupture than in adults. This could be due to the fact that most pediatric AVMs are only detected after rupture. We aimed to review the current literature regarding the natural history and the clinical outcome after multimodality AVM treatment in the pediatric population, as optimal management for pediatric AVMs remains controversial. A multidisciplinary approach using multimodality therapy if needed has been proved to be beneficial in approaching these lesions in all age groups. Microsurgical resection remains the gold standard for the treatment of all accessible pediatric AVMs. Embolization and radiosurgery should be considered as an adjunctive therapy. Embolization provides a useful adjunct therapy to microsurgery by preventing significant blood loss and to radiosurgery by decreasing the volume of the AVM. Radiosurgery has been described to provide an alternative treatment approach in certain circumstances either as a primary or adjuvant therapy.
- Published
- 2016
- Full Text
- View/download PDF
22. Performance and Predictive Value of a User-Independent Platform for CT Perfusion Analysis: Threshold-Derived Automated Systems Outperform Examiner-Driven Approaches in Outcome Prediction of Acute Ischemic Stroke.
- Author
-
Dehkharghani S, Bammer R, Straka M, Albin LS, Kass-Hout O, Allen JW, Rangaraju S, Qiu D, Winningham MJ, and Nahab F
- Subjects
- Aged, Brain diagnostic imaging, Cerebrovascular Circulation physiology, Disease Progression, Female, Humans, Male, Middle Aged, Prognosis, ROC Curve, Retrospective Studies, Tomography, X-Ray Computed methods, Brain Ischemia diagnostic imaging, Image Processing, Computer-Assisted, Perfusion Imaging, Stroke diagnostic imaging
- Abstract
Background and Purpose: Treatment strategies in acute ischemic stroke aim to curtail ischemic progression. Emerging paradigms propose patient subselection using imaging biomarkers derived from CT, CTA, and CT perfusion. We evaluated the performance of a fully-automated computational tool, hypothesizing enhancements compared with qualitative approaches. The correlation between imaging variables and clinical outcomes in a cohort of patients with acute ischemic stroke is reported., Materials and Methods: Sixty-two patients with acute ischemic stroke and MCA or ICA occlusion undergoing multidetector CT, CTA, and CTP were retrospectively evaluated. CTP was processed on a fully operator-independent platform (RApid processing of PerfusIon and Diffusion [RAPID]) computing automated core estimates based on relative cerebral blood flow and relative cerebral blood volume and hypoperfused tissue volumes at varying thresholds of time-to-maximum. Qualitative analysis was assigned by 2 independent reviewers for each variable, including CT-ASPECTS, CBV-ASPECTS, CBF-ASPECTS, CTA collateral score, and CTA clot burden score. Performance as predictors of favorable clinical outcome and final infarct volume was established for each variable., Results: Both RAPID core estimates, CT-ASPECTS, CBV-ASPECTS, and clot burden score correlated with favorable clinical outcome (P < .05); CBF-ASPECTS and collateral score were not significantly associated with favorable outcome, while hypoperfusion estimates were variably associated, depending on the selected time-to-maximum thresholds. Receiver operating characteristic analysis demonstrated disparities among tested variables, with RAPID core and hypoperfusion estimates outperforming all qualitative approaches (area under the curve, relative CBV = 0.86, relative CBF = 0.81; P < .001)., Conclusions: Qualitative approaches to acute ischemic stroke imaging are subject to limitations due to their subjective nature and lack of physiologic information. These findings support the benefits of high-speed automated analysis, outperforming conventional methodologies while limiting delays in clinical management., (© 2015 by American Journal of Neuroradiology.)
- Published
- 2015
- Full Text
- View/download PDF
23. Clinical, angiographic and radiographic outcome differences among mechanical thrombectomy devices: initial experience of a large-volume center.
- Author
-
Kass-Hout T, Kass-Hout O, Sun CH, Kass-Hout T, Belagaje S, Anderson A, Frankel M, Gupta R, and Nogueira R
- Subjects
- Aged, Aged, 80 and over, Cohort Studies, Female, Humans, Male, Mechanical Thrombolysis standards, Middle Aged, Retrospective Studies, Treatment Outcome, Brain Ischemia diagnostic imaging, Brain Ischemia therapy, Cerebral Angiography methods, Mechanical Thrombolysis instrumentation, Stroke diagnostic imaging, Stroke therapy
- Abstract
Background and Purpose: Higher reperfusion rates have been established with endovascular treatment of acute ischemic stroke (AIS). There are limited data on the comparative performance of mechanical thrombectomy devices., Methods: A retrospective single-center analysis was undertaken of all consecutive patients who underwent thrombectomy using Merci, Penumbra or stent retrievers (SR) from September 2010 to November 2012. Baseline characteristics, rates of successful recanalization (modified Thrombolysis in Cerebral Infarction (mTICI) score 2b-3), symptomatic intracerebral hemorrhage (sICH), final infarct volume, 90-day mortality and independent functional outcomes at 90 days were compared across the three devices., Results: Our cohort included 287 patients. There were mild imbalances in baseline characteristics with trends towards higher National Institutes of Health Stroke Scale (NIHSS) score in patients in the Merci group (SR=18 vs Merci=21 vs Penumbra=19, p=0.06) and lower Alberta Stroke Program Early CT Score (ASPECTS) in patients in the SR group (>7: SR=51% vs Merci=61% vs Penumbra=62%, p=0.12). On univariate analysis there were no differences in the rate of sICH (SR=7% vs Merci=7% vs Penumbra=6%, p=0.921) and infarct volume (SR=61.5 mL vs Merci=69.5 mL vs Penumbra=59.2 mL, p=0.621). Trends towards better functional outcomes were found with Penumbra and SR vs Merci (41% vs 36% vs 25%, respectively, p=0.079). Complete or near complete reperfusion (mTICI 2b-3) was higher in the SR and Penumbra groups than in the Merci group (86% vs 78% vs 70%, respectively, p=0.027). Binary logistic regression showed that SR was an independent predictor of good functional outcome (OR 2.27, 95% CI 1.018 to 5.048; p=0.045)., Conclusions: Although our initial data confirm the superiority of SR technology over the Merci device, there was no significant difference in near complete/complete reperfusion, final infarct volumes or clinical outcomes between SR and Penumbra thromboaspiration., (Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.)
- Published
- 2015
- Full Text
- View/download PDF
24. Periprocedural cost-effectiveness analysis of mechanical thrombectomy for acute ischemic stroke in the stent retriever era.
- Author
-
Kass-Hout T, Kass-Hout O, Sun CH, Kass-Hout T, Belagaje SR, Anderson AM, Frankel MR, Gupta R, and Nogueira RG
- Abstract
Background: Early reperfusion is critical for favorable outcomes in acute ischemic stroke (AIS). Stent retrievers lead to faster and more complete reperfusion than previous technologies. Our aim is to compare the cost-effectiveness of stent retrievers to the previous mechanical thrombectomy devices., Methods: Retrospective review of endovascularly treated large-vessel AIS. Data from all consecutive patients who underwent thrombectomy from January 2012 through November 2012 were collected. Baseline characteristics, the total procedural cost, the rates of successful recanalization [modified thrombolysis in cerebral ischemia (mTICI) scores of 2b or 3], and the length of stay at the hospital were compared between the stent retriever (SR) and the non-stent retriever (NSR) groups., Results: After excluding the patients who underwent concomitant extracranial stenting (n = 22) or received intra-arterial tissue plasminogen activator only (n = 6), the entire cohort included 150 patients. The cost of the reperfusion procedure was significantly higher in the SR compared to the NSR group (USD 13,419 vs. 9,308, p <0.001). We were unable to demonstrate a statistically significant difference in the rates of mTICI 2b/3 reperfusion (81 vs. 74%, p = 0.337) or the length of stay (11.1 ± 9.1 vs. 12.8 ± 9.6 days, p = 0.260) amongst the SR and the NSR patients., Conclusion: The procedural costs of thrombectomy for AIS are increasing and account for the bulk of hospitalization reimbursement. The impact of these expenditures in the long-term sustainability of stroke centers deserves greater consideration. While it is likely that the SR technology results in higher rates of optimal reperfusion, better clinical outcomes, and shorter lengths of stay, larger studies are needed to prove its cost-effectiveness.
- Published
- 2015
- Full Text
- View/download PDF
25. A novel approach to diagnose reversible cerebral vasoconstriction syndrome: a case series.
- Author
-
Kass-Hout T, Kass-Hout O, Sun CH, Kass-Hout T, Ramakrishnan P, Nahab F, Nogueira R, and Gupta R
- Subjects
- Adult, Diagnosis, Differential, Female, Humans, Infusions, Intra-Arterial, Male, Middle Aged, Young Adult, Headache Disorders, Primary diagnosis, Milrinone administration & dosage, Nicardipine administration & dosage, Vasoconstriction drug effects, Vasodilator Agents administration & dosage, Vasospasm, Intracranial diagnosis
- Abstract
Background: Reversible cerebral vasoconstriction syndrome (RCVS) is classically diagnosed based on the presence of severe thunderclap headache, focal neurologic symptoms, and the radiographic findings of reversible diffuse segmental cerebral vasoconstriction. We present a diagnostic test that may assist in the clinical diagnosis and facilitate treatment., Methods: From October 1, 2010, to August 1, 2013, we identified consecutive patients who presented with a presumptive diagnosis of RCVS and underwent cerebral diagnostic angiography with intra-arterial (IA) vasodilator therapy. Medical records including clinical presentation, radiographic, and angiographic images were all reviewed., Results: We identified a total of 7 patients (4 females; age range, 22-56; mean, 45 years) who met our inclusion criteria. Four patients received a combination of milrinone and nicardipine infusion either in the internal carotid arteries or in the left vertebral artery; the remaining patients received IA therapy solely with either nicardipine or milrinone. Five patients had a positive angiographic response, defined as significant improvement or resolution of the blood vessels irregularities. All 5 patients had a definite discharge diagnosis of RCVS. The remaining 2 patients had a negative angiographic response and based on their clinical and radiographic course had a final diagnosis of intracranial atherosclerotic disease., Conclusions: Our small case series suggest that IA administration of vasodilators is safe and may aid in distinguishing vasodilator responsive syndromes such as RCVS from other causes. Further study is required with long-term clinical outcome to determine the utility of this diagnostic test., (Copyright © 2015. Published by Elsevier Inc.)
- Published
- 2015
- Full Text
- View/download PDF
26. Is bridging with intravenous thrombolysis of any benefit in endovascular therapy for acute ischemic stroke?
- Author
-
Kass-Hout T, Kass-Hout O, Mokin M, Thesier DM, Yashar P, Orion D, Jahshan S, Hopkins LN, Siddiqui AH, Snyder KV, and Levy EI
- Subjects
- Brain Ischemia mortality, Cerebral Infarction therapy, Female, Humans, Male, Retrospective Studies, Stroke mortality, Tissue Plasminogen Activator administration & dosage, Tissue Plasminogen Activator therapeutic use, Treatment Outcome, Brain Ischemia surgery, Brain Ischemia therapy, Endovascular Procedures methods, Fibrinolytic Agents administration & dosage, Fibrinolytic Agents therapeutic use, Stroke surgery, Stroke therapy, Thrombolytic Therapy methods
- Abstract
Objective: Large vessel occlusions with heavy clot burden are less likely to improve with intravenous (IV) thrombolysis alone. The purpose of this study was to show whether a combination of IV thrombolysis and endovascular therapy was superior to endovascular treatment alone., Methods: Data for 104 patients with acute large artery occlusion treated between 2005 and 2010 were reviewed. Forty-two received endovascular therapy in combination with IV thrombolysis (bridging group), and 62 received endovascular therapy only. Clinical outcome, mortality rate, and symptomatic intracranial hemorrhage (sICH) rate were compared between the two groups., Results: The two groups had similar demographic and vascular risk factor distribution, as well as National Institutes of Health Stroke Scale score on admission (mean±SD: 14.8±4.7 and 16.0±5.3; P=0.23). No difference was found in Thrombolysis in Myocardial Infarction recanalization rates (score of 2 or 3) after combined or endovascular therapy alone (83.33% and 79.03%; P=0.585). Favorable outcome, defined as a modified Rankin Scale score of <2 at 90 days, also did not differ between the bridging group and the endovascular-only group (37.5% and 32.76%; P=0.643). There was no difference in mortality rate (19.04% and 29.03%; P=0.5618) and sICH rate (11.9% and 9.68%; P=0.734). A significant difference was found in mean time from symptom onset to treatment in the bridging group and the endovascular-only group (227±88 min vs. 125±40 min; P<0.0001)., Conclusion: Combining IV thrombolysis with endovascular therapy resulted in similar outcome, revascularization, sICH, and mortality rates compared with endovascular therapy alone. Prospective clinical studies comparing both treatment strategies in acute ischemic stroke are warranted., (Copyright © 2014 Elsevier Inc. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
27. Intravenous heparin for the treatment of intraluminal thrombus in patients with acute ischemic stroke: a case series.
- Author
-
Mokin M, Kass-Hout T, Kass-Hout O, Radovic V, Siddiqui AH, Levy EI, and Snyder KV
- Subjects
- Aged, Aged, 80 and over, Brain Ischemia complications, Brain Ischemia diagnosis, Female, Humans, Infusions, Intravenous, Intracranial Thrombosis complications, Intracranial Thrombosis diagnosis, Male, Middle Aged, Prospective Studies, Retrospective Studies, Stroke complications, Stroke diagnosis, Treatment Outcome, Brain Ischemia drug therapy, Heparin administration & dosage, Intracranial Thrombosis drug therapy, Stroke drug therapy
- Abstract
Background and Objectives: Current American Stroke Association/American Heart Association recommendations on the management of acute ischemic stroke do not recommend the early use of heparin because of an increased risk of bleeding complications. However, for select patients, such as those with strokes associated with non-occlusive intraluminal thrombus, intravenous heparin might prove to be beneficial., Methods: A retrospective analysis of acute ischemic stroke cases associated with non-occlusive intraluminal thrombus of intracranial and extracranial arteries in the corresponding vascular territories was conducted to identify patients in whom treatment with intravenous heparin resulted in near-complete or complete lysis of the thrombus. Imaging findings from CT perfusion and angiography, MRI, and/or digital subtraction angiography were used to describe the location of intraluminal thrombus immediately before and after treatment with intravenous heparin., Results: 18 patients with nonocclusive intraluminal thrombus confirmed by CT angiography (CTA) received treatment with intravenous heparin alone (median duration 3.5 days; range 1-8 days). The median National Institutes of Health stroke scale score was 2.5 (range 0-15) on admission and 1 (range 0-9) at discharge. Nine patients had complete lysis, and nine patients had partial lysis of the thrombus with improved flow distal to the location of the thrombus. None of the patients developed intracranial hemorrhage., Conclusion: For strokes associated with intraluminal thrombus, intravenous heparin might prove to be an effective treatment strategy. Further studies are necessary to evaluate the efficacy and safety of treatment with intravenous heparin in those patients.
- Published
- 2013
- Full Text
- View/download PDF
28. Blood pressure management and evolution of thrombolysis-associated intracerebral hemorrhage in acute ischemic stroke.
- Author
-
Mokin M, Kass-Hout T, Kass-Hout O, Zivadinov R, and Mehta B
- Subjects
- Aged, Aged, 80 and over, Cerebral Hemorrhage diagnostic imaging, Cerebral Hemorrhage physiopathology, Disease Progression, Female, Fibrinolytic Agents administration & dosage, Hematoma diagnostic imaging, Hematoma physiopathology, Humans, Male, Middle Aged, Retrospective Studies, Systole, Time Factors, Tissue Plasminogen Activator administration & dosage, Tomography, X-Ray Computed, Antihypertensive Agents therapeutic use, Blood Pressure drug effects, Brain Ischemia drug therapy, Cerebral Hemorrhage chemically induced, Fibrinolytic Agents adverse effects, Hematoma chemically induced, Stroke drug therapy, Thrombolytic Therapy adverse effects, Tissue Plasminogen Activator adverse effects
- Abstract
Background: There is limited knowledge on the radiographic features of thrombolysis-induced hemorrhage. The factors that influence early hematoma expansion have not been elucidated., Methods: Patients presenting with a symptomatic intracerebral hemorrhage (ICH) as a result of intravenous (IV) thrombolysis with tissue plasminogen activator (tPA) for acute ischemic stroke and had noncontrast computed tomographic (CT) scans of the head were included in this retrospective study. Calculation of hematoma volumes was obtained. Analysis of covariance was used to evaluate for the effect of baseline blood pressure (BP) on initial hematoma volume and further growth., Results: Of 267 patients who were treated with intravenous tPA for acute ischemic stroke at our facility between January 1, 2005 and December 31, 2009, 17 patients developed symptomatic ICH and were included in the final analysis. There was a positive correlation between baseline level of systolic BP after thrombolysis and initial hematoma volume (r = 0.46; P = .03) but not for the diastolic BP (r = 0.07; P = .40). There was a significant increase in mean hematoma volume expansion when comparing results between the first and second CT scans (median 9 hours, 22 minutes; 14.9 ± 19.6 cm(3) to 26.0 ± 26.7 cm(3); P = .04). There was also a negative association between the reduction of systolic BP and hematoma growth (r = -0.67; P = .02), but no correlation with change in diastolic BP (r = -0.22; P = .28)., Conclusions: Once diagnosed, thrombolysis-induced symptomatic ICH undergoes significant early expansion in size. Systolic BP may play a role in hematoma expansion., (Copyright © 2012 National Stroke Association. Published by Elsevier Inc. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
29. Intravenous thrombolysis and endovascular therapy for acute ischemic stroke with internal carotid artery occlusion: a systematic review of clinical outcomes.
- Author
-
Mokin M, Kass-Hout T, Kass-Hout O, Dumont TM, Kan P, Snyder KV, Hopkins LN, Siddiqui AH, and Levy EI
- Subjects
- Angioplasty, Brain Ischemia mortality, Humans, Injections, Intra-Arterial, Injections, Intravenous, Stents, Stroke mortality, Thrombectomy, Tissue Plasminogen Activator administration & dosage, Tissue Plasminogen Activator therapeutic use, Treatment Outcome, Brain Ischemia drug therapy, Carotid Stenosis complications, Endovascular Procedures, Fibrinolytic Agents administration & dosage, Fibrinolytic Agents therapeutic use, Stroke drug therapy, Thrombolytic Therapy
- Abstract
Background and Purpose: Strokes secondary to acute internal carotid artery (ICA) occlusion are associated with extremely poor prognosis. The best treatment approach to acute stroke in this setting is unknown. We sought to determine clinical outcomes in patients with acute ischemic stroke attributable to ICA occlusion treated with intravenous (IV) systemic thrombolysis or intra-arterial endovascular therapy., Methods: Using the PubMed database, we searched for studies that included patients with acute ischemic stroke attributable to ICA occlusion who received treatment with IV thrombolysis or intra-arterial endovascular interventions. Studies providing data on functional outcomes beyond 30 days and mortality and symptomatic intracerebral hemorrhage (sICH) rates were included in our analysis. We compared the proportions of patients with favorable functional outcomes, sICH, and mortality rates in the 2 treatment groups by calculating χ(2) and confidence intervals for odds ratios., Results: We identified 28 studies with 385 patients in the IV thrombolysis group and 584 in the endovascular group. Rates of favorable outcomes and sICH were significantly higher in the endovascular group than the IV thrombolysis-only group (33.6% vs 24.9%, P=0.004 and 11.1% vs 4.9%, P=0.001, respectively). No significant difference in mortality rate was found between the groups (27.3% in the IV thrombolysis group vs 32.0% in the endovascular group; P=0.12)., Conclusions: According to our systematic review, endovascular treatment of acute ICA occlusion results in improved clinical outcomes. A higher rate of sICH after endovascular treatment does not result in increased overall mortality rate.
- Published
- 2012
- Full Text
- View/download PDF
30. "Chasing the dragon"--heroin-associated spongiform leukoencephalopathy.
- Author
-
Kass-Hout T, Kass-Hout O, Darkhabani MZ, Mokin M, Mehta B, and Radovic V
- Subjects
- Administration, Inhalation, Brain pathology, Cerebellum pathology, Dysarthria chemically induced, Dysarthria psychology, Humans, Magnetic Resonance Imaging, Male, Nystagmus, Pathologic chemically induced, Smoke, Young Adult, Heroin adverse effects, Heroin Dependence complications, Leukoencephalopathies chemically induced, Substance Abuse, Intravenous complications
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.